Skye Bioscience, Inc.
SKYE · XNASCIK 1516551fmd_11HGJVBXZW4PMA8YW9HJZ0NRSHManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Nov 01, 2011 to Jun 30, 2026, 61 periods
AI-written
A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.
Loading